---
title: "3SBio Shareholders Back Spin-Off Dividend of Mandi Inc. Shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283843251.md"
description: "3SBio shareholders have approved a resolution to distribute all shares of subsidiary Mandi Inc. as a special dividend, with 99.995% support at an extraordinary general meeting on April 23, 2026. This move aims to advance the spin-off strategy and reshape the company's capital structure. The board has been granted authority to determine distribution mechanics, reflecting strong investor backing. The latest analyst rating for 3SBio (HK:1530) is a Hold with a price target of HK$29.43, and the company operates in the biopharmaceutical sector with a market cap of HK$62.99B."
datetime: "2026-04-23T13:12:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283843251.md)
  - [en](https://longbridge.com/en/news/283843251.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283843251.md)
---

# 3SBio Shareholders Back Spin-Off Dividend of Mandi Inc. Shares

### Claim 30% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

3SBio ( (HK:1530) ) has shared an update.

3SBio shareholders have approved an ordinary resolution at an extraordinary general meeting held on 23 April 2026 to distribute all shares of subsidiary Mandi Inc. as a conditional special dividend in specie. The vote, overseen by Computershare Hong Kong Investor Services as scrutineer, passed with 99.995% support and grants the board broad authority to determine the exact distribution mechanics, advancing the planned spin-off and potentially reshaping the group’s capital structure and asset portfolio.

With no voting restrictions or stated plans by any party to oppose or abstain, the outcome reflects strong investor backing for the spin-off strategy. The move signals management’s intent to unlock value from Mandi Inc. for qualifying shareholders while giving directors flexibility to finalize record dates, allocation formulas, and transfer arrangements within applicable legal and regulatory requirements.

The most recent analyst rating on (HK:1530) stock is a Hold with a HK$29.43 price target. To see the full list of analyst forecasts on 3SBio stock, see the HK:1530 Stock Forecast page.

**More about 3SBio**

3SBio Inc., incorporated in the Cayman Islands and listed in Hong Kong, operates in the biopharmaceutical sector. The company focuses on developing and commercializing innovative therapies, and it maintains a substantial shareholder base with more than 2.5 billion issued shares eligible to vote on key corporate actions.

**Average Trading Volume:** 27,729,236

**Technical Sentiment Signal:** Buy

**Current Market Cap:** HK$62.99B

For a thorough assessment of 1530 stock, go to TipRanks’ Stock Analysis page.

### Related Stocks

- [01530.HK](https://longbridge.com/en/quote/01530.HK.md)
- [CPU.AU](https://longbridge.com/en/quote/CPU.AU.md)
- [688336.CN](https://longbridge.com/en/quote/688336.CN.md)

## Related News & Research

- [Pulse Seismic Inc. Announces Voting Results at Shareholders' Annual Meeting | PLSDF Stock News](https://longbridge.com/en/news/284649157.md)
- [Thomson Reuters Announces Voting Results of Return of Capital and Share Consolidation Transactions | TRI Stock News](https://longbridge.com/en/news/284448684.md)
- [Mattr Announces Amendment to Director Nominee Slate for Its Annual Meeting | MTTRF Stock News](https://longbridge.com/en/news/284836892.md)
- [Rokeby Resources Calls Physical-Only General Meeting, Urges Early Proxy Voting](https://longbridge.com/en/news/284860713.md)
- [Xiamen Jihong Calls 2026 EGM to Seek Mandate for New H Share Issuance](https://longbridge.com/en/news/284236630.md)